Literature DB >> 11041367

Intracellular vesicular trafficking of tyrosinase gene family protein in eu- and pheomelanosome biogenesis.

K Jimbow1, C Hua, P F Gomez, K Hirosaki, K Shinoda, T G Salopek, H Matsusaka, H Y Jin, T Yamashita.   

Abstract

The intracellular vesicular trafficking in the melanosome biogenesis (melanogenesis) is reviewed with the incorporation of our own experimental findings. The melanosome biogenesis involves four stages of melanosome maturation, which reflect the transport of structural and enzymatic proteins from Golgi (trans-Golgi network: TGN) to the melanosomal compartment and their organization therein. The major melanosomal proteins include tyrosinase gene family protein (tyrosinase and tyrosinase-related protein; TRP), lysosome-associated membrane protein (Lamp) and gp100 (pmel 17). They are glycosylated in the endoplasmic reticulum, and transported by vesicles from the TGN to the melanosomal compartment. During the formation of transport vesicles, they assemble on the cytoplasmic face of the TGN to select cargo by interacting directly or indirectly with coat proteins. Tyrosinase and TRP-1 possess the dileucine motifs at the cytoplasmic domain, to which adapter protein-3 binds to transport them from the TGN to stage I melanosomes (related to late endosomes) and then to stage II melanosomes. A number of small guanosine triphosphate-binding proteins, including rab 7, appear to be involved in this vesicular transport. Phosphatidyl inositol 3 kinase also regulates this membrane trafficking of melanosomal glycoprotein. Eumelanogenesis is controlled by melanocyte-stimulating hormone, and all three tyrosinase gene family proteins are transported from the TGN to stage II melanosomes that are elliposoidal and contain the structural matrix of filaments/lamellae. In contrast, pheomelanogenesis is primarily regulated by agouti signal protein, and only tyrosinase is transported from stage I melanosomes to stage II melanosomes that are spherical and related to lysosomes. Because of the absence of TRP-1 and TRP-2 in pheomelanogenesis, it may be suggested that tyrosinase is involved in lysosomal degradation after forming dopaquinone, to which the cysteine present in the lysosomal granule binds to form cysteinyldopas that will then be auto-oxidized to become pheomelanin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11041367     DOI: 10.1034/j.1600-0749.13.s8.20.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  13 in total

1.  Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.

Authors:  Hongmei Nan; Peter Kraft; David J Hunter; Jiali Han
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

2.  Melanophilin, the product of the leaden locus, is required for targeting of myosin-Va to melanosomes.

Authors:  D William Provance; Ted L James; John A Mercer
Journal:  Traffic       Date:  2002-02       Impact factor: 6.215

3.  Genome-wide association study of tanning phenotype in a population of European ancestry.

Authors:  Hongmei Nan; Peter Kraft; Abrar A Qureshi; Qun Guo; Constance Chen; Susan E Hankinson; Frank B Hu; Gilles Thomas; Robert N Hoover; Stephen Chanock; David J Hunter; Jiali Han
Journal:  J Invest Dermatol       Date:  2009-04-02       Impact factor: 8.551

4.  Transcriptome analysis provides insight into the role of the melanin pathway in two differently pigmented strains of the turtle Pelodiscus sinensis.

Authors:  Yuexiu Si; Lili Zhang; Linmeng Zhang; Feng Zhao; Qian Wang; Guoying Qian; Shangjun Yin
Journal:  Dev Genes Evol       Date:  2019-11-11       Impact factor: 0.900

5.  Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.

Authors:  Kowichi Jimbow; Yasue Ishii-Osai; Shosuke Ito; Yasuaki Tamura; Akira Ito; Akihiro Yoneta; Takafumi Kamiya; Toshiharu Yamashita; Hiroyuki Honda; Kazumasa Wakamatsu; Katsutoshi Murase; Satoshi Nohara; Eiichi Nakayama; Takeo Hasegawa; Itsuo Yamamoto; Takeshi Kobayashi
Journal:  J Skin Cancer       Date:  2013-02-21

Review 6.  Pharmacologic manipulation of skin pigmentation.

Authors:  Gabriel H Kindl; John A D'Orazio
Journal:  Pigment Cell Melanoma Res       Date:  2021-03-12       Impact factor: 4.159

Review 7.  Making region-specific integumentary organs in birds: evolution and modifications.

Authors:  Chih-Kuan Chen; Wen-Tau Juan; Ya-Chen Liang; Ping Wu; Cheng-Ming Chuong
Journal:  Curr Opin Genet Dev       Date:  2021-03-27       Impact factor: 4.665

8.  Complete association between a retroviral insertion in the tyrosinase gene and the recessive white mutation in chickens.

Authors:  Chung-Ming Chang; Jean-Luc Coville; Gérard Coquerelle; David Gourichon; Ahmad Oulmouden; Michèle Tixier-Boichard
Journal:  BMC Genomics       Date:  2006-02-05       Impact factor: 3.969

9.  Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway.

Authors:  Tokimasa Hida; Kazumasa Wakamatsu; Elena V Sviderskaya; Andrew J Donkin; Lluis Montoliu; M Lynn Lamoreux; Bin Yu; Glenn L Millhauser; Shosuke Ito; Gregory S Barsh; Kowichi Jimbow; Dorothy C Bennett
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-26       Impact factor: 4.693

10.  New Whitening Constituents from Taiwan-Native Pyracantha koidzumii: Structures and Tyrosinase Inhibitory Analysis in Human Epidermal Melanocytes.

Authors:  Rong-Dih Lin; Mei-Chuan Chen; Yan-Ling Liu; Yi-Tzu Lin; Mei-Kuang Lu; Feng-Lin Hsu; Mei-Hsien Lee
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.